HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guglielmo Borgia Selected Research

stearoylarachidonylglycerol

1/2019The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guglielmo Borgia Research Topics

Disease

33Infections
01/2020 - 01/2003
13Fibrosis (Cirrhosis)
01/2020 - 02/2009
12Chronic Hepatitis C
12/2015 - 01/2003
8Hepatitis C
01/2020 - 08/2010
6Hepatocellular Carcinoma (Hepatoma)
01/2020 - 03/2014
6Liver Cirrhosis (Hepatic Cirrhosis)
10/2017 - 03/2014
5Disease Progression
01/2019 - 08/2010
4Liver Diseases (Liver Disease)
10/2019 - 01/2016
4Peritonitis
01/2019 - 07/2017
4Autism Spectrum Disorder
07/2014 - 05/2013
3Ascites
01/2020 - 03/2014
3Multiple Sclerosis
01/2019 - 03/2008
3Hepatitis
01/2018 - 12/2003
3Persistent Infection
10/2015 - 07/2013
3Autistic Disorder (Autism)
07/2014 - 11/2013
3HIV Infections (HIV Infection)
04/2014 - 06/2009
3Varicose Veins (Varicose Vein)
03/2014 - 01/2009
2Pneumonia (Pneumonitis)
01/2019 - 01/2019
2Communicable Diseases (Infectious Diseases)
01/2018 - 03/2015
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1Alcoholism (Alcohol Abuse)
01/2020
1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Sepsis (Septicemia)
01/2020
1Chronic Renal Insufficiency
01/2019
1Bacterial Pneumonia
01/2019
1Atrial Fibrillation
01/2019
1Invasive Fungal Infections
01/2019
1Pleural Effusion (Pleural Effusions)
01/2019
1Pulmonary Tuberculosis
01/2019
1Respiratory Insufficiency (Respiratory Failure)
01/2019
1Invasive Pulmonary Aspergillosis
01/2019
1Crohn Disease (Crohn's Disease)
01/2019
1Opportunistic Infections (Opportunistic Infection)
01/2018
1Virus Diseases (Viral Diseases)
01/2018
1Relapsing-Remitting Multiple Sclerosis
01/2018
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2018
1Lymphopenia (Lymphocytopenia)
01/2018
1Vitamin D Deficiency
10/2017
1Critical Illness (Critically Ill)
01/2017
1Liver Failure
01/2017
1Tuberculosis (Tuberculoses)
01/2017
1Osteomyelitis
01/2017
1Human Influenza (Influenza)
08/2015
1Clostridium Infections
07/2015
1Cryoglobulinemia
05/2015

Drug/Important Bio-Agent (IBA)

22Antiviral Agents (Antivirals)IBA
01/2020 - 08/2010
17InterferonsIBA
01/2017 - 03/2008
11Ribavirin (Virazole)FDA LinkGeneric
01/2017 - 05/2005
7Pharmaceutical PreparationsIBA
01/2019 - 03/2010
7AntibodiesIBA
07/2014 - 06/2004
4VaccinesIBA
01/2018 - 09/2012
4Protease Inhibitors (Protease Inhibitor)IBA
05/2014 - 01/2014
3Vitamin DFDA LinkGeneric
01/2019 - 05/2015
3Biological ProductsIBA
01/2018 - 12/2003
3NucleosidesIBA
10/2014 - 02/2009
3Immunoglobulins (Immunoglobulin)IBA
09/2012 - 12/2003
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020 - 07/2017
2Alemtuzumab (Campath)FDA Link
01/2019 - 01/2018
2Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2018 - 01/2013
2Anti-Bacterial Agents (Antibiotics)IBA
07/2017 - 03/2015
2SofosbuvirIBA
12/2015 - 01/2014
2asunaprevirIBA
10/2015 - 01/2014
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
05/2014 - 01/2014
2telaprevirIBA
05/2014 - 01/2014
2Interferon-alpha (Interferon Alfa)IBA
07/2013 - 01/2003
2Prothrombin (Factor II)IBA
05/2013 - 01/2013
1Carbapenems (Carbapenem Antibiotics)IBA
01/2020
1Colistin (Coly-Mycin)FDA Link
01/2020
1CurcuminIBA
10/2019
1Monoclonal AntibodiesIBA
01/2019
1bis(p-chlorophenyl)acetic acid (DDA)IBA
01/2019
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2019
1beta-Lactamases (beta-Lactamase)IBA
01/2019
1Infliximab (Remicade)FDA Link
01/2019
1Interferon-betaIBA
01/2019
1stearoylarachidonylglycerolIBA
01/2019
1Phosphodiesterase 5 InhibitorsIBA
11/2018
1Viral DNAIBA
09/2018
1AntigensIBA
01/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2017
1acarboxyprothrombin (PIVKA)IBA
07/2017
1tazobactam drug combination ceftolozaneIBA
01/2017
1Vitamin KFDA Link
01/2017
1Inosine TriphosphataseIBA
01/2017
1AnticoagulantsIBA
01/2017
1daclatasvirIBA
10/2015
1Influenza Vaccines (Influenza Vaccine)FDA Link
08/2015
1hydroxide ionIBA
05/2015
1CryoglobulinsIBA
05/2015
18- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
01/2015
1sofosbuvir drug combination ledipasvirIBA
12/2014
1GS-9669IBA
10/2014
1Peptidyl Transferases (Peptidyltransferase)IBA
09/2014
1ombitasvirIBA
09/2014

Therapy/Procedure

20Therapeutics
01/2020 - 01/2003
2Drug Therapy (Chemotherapy)
08/2018 - 07/2013
2Highly Active Antiretroviral Therapy (HAART)
01/2013 - 06/2009
1Treatment Delay
12/2017
1Retreatment
01/2017
1Fecal Microbiota Transplantation
07/2015